MyLife Technologies
Development and commercialization of innovative ceramic microneedle patches for painless and efficient intradermal delivery of vaccines and drugs.
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Spinout | ||
| Total Funding | 000k | ||
Related Content
MyLife Technologies specializes in the development of nano porous Micro Needle Arrays (npMNA) designed for efficient vaccine delivery and pharmaceutical applications. The company operates in the healthcare and pharmaceutical sectors, focusing on innovative drug delivery systems. Its core product, the ceramic skin patch, is engineered to enhance the formulation and delivery of active pharmaceutical ingredients (APIs) and vaccines. MyLife Technologies collaborates with partners and customers to tailor its npMNA technology to specific needs, ensuring optimal load and release characteristics. The business model revolves around research and development, leveraging expertise in ceramic material science and molecular biology to create patented solutions. Revenue is generated through partnerships, licensing agreements, and direct sales of its proprietary technology. The company serves pharmaceutical companies and research institutions seeking advanced drug delivery methods.
Keywords: nano porous, Micro Needle Arrays, vaccine delivery, pharmaceutical applications, ceramic skin patches, drug delivery systems, healthcare, molecular biology, ceramic material science, research and development.